EDGAR Filing Documents for 0000000000-13-060562

Form UPLOAD - SEC-generated letter:

SEC Accession No. 0000000000-13-060562

Filing Date

2013-11-04

Accepted

2013-11-04 16:23:21

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.pdf	LETTER	115229
	Complete submission text file	0000000000-13-060562.txt		159868

Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020

ContraVir Pharmaceuticals, Inc. (Filed for) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations